Portable EEG Machine for Clinical & Mobile Neurodiagnostics

NCC MEDICAL GROUP is a globally recognized manufacturer specializing in neurodiagnostic and neuro-monitoring technologies. Since its establishment in 1997, the company has been dedicated to advancing clinical neurophysiology through innovative medical devices, including Eeg Machine Portable, intraoperative neurophysiological monitoring systems, electromyography equipment, and sleep diagnostic solutions.

As a nationally recognized SRDI “Little Giant” enterprise, NCC represents a group of technology-driven companies that demonstrate strong capabilities in specialized research, refined manufacturing processes, differentiated product innovation, and proprietary intellectual property development. This recognition highlights NCC’s commitment to technological leadership and its contribution to the advancement of neurological healthcare.

The company’s research and development headquarters and primary manufacturing base are located in Shanghai, China. This facility serves as the core innovation center for the development of advanced neurophysiology technologies including high-precision EEG amplifiers, intelligent signal analysis algorithms, and integrated neurological monitoring systems such as the Eeg Machine Portable.

To ensure global compliance and quality assurance, NCC maintains an international quality and regulatory hub in Singapore. This strategic structure allows the company to align product development with global medical standards while supporting international distribution and regulatory certification processes.

NCC MEDICAL GROUP focuses on several key product categories including EEG and PSG diagnostic systems, intraoperative neurophysiological monitoring solutions, EMG diagnostic platforms, and a comprehensive range of medical consumables. Among these innovations, the Eeg Machine Portable represents a major advancement in mobile neurodiagnostic technology, enabling clinicians to perform accurate brain monitoring across diverse clinical environments.

The company’s global operational structure is built upon three primary pillars. The first pillar focuses on research and manufacturing in China, where multidisciplinary engineering teams develop cutting-edge neurophysiology technologies and implement precision manufacturing processes. The second pillar centers on global sales and distribution, supported by regional hubs and a growing network of international partners and distributors. The third pillar emphasizes service innovation through platforms such as the NeuGuard Service Platform and the NCC Innovation Academy, which provide technical training, clinical education, and ongoing professional support for healthcare institutions.

NCC’s technologies are currently used in more than 50 countries and over 5,000 hospitals across China. The company’s clinical solutions are trusted by teaching hospitals, neurological research institutes, and regional medical centers worldwide. Through continuous innovation and collaboration with medical professionals, NCC strives to improve neurological diagnostics and enhance patient care.

Guided by its mission of safeguarding life and health, NCC MEDICAL GROUP remains committed to advancing safer surgical procedures, more accurate neurological diagnosis, and higher standards of patient treatment through technologies such as the Eeg Machine Portable.